188 related articles for article (PubMed ID: 11141494)
1. Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast.
Jones C; Damiani S; Wells D; Chaggar R; Lakhani SR; Eusebi V
Am J Pathol; 2001 Jan; 158(1):207-14. PubMed ID: 11141494
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
3. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
4. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
5. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous apocrine mixed tumor: derived from the apocrine duct of the folliculo-sebaceous-apocrine unit?
Gianotti R; Coggi A; Alessi E
Am J Dermatopathol; 1998 Jun; 20(3):323-5. PubMed ID: 9650712
[TBL] [Abstract][Full Text] [Related]
7. Apocrine metaplasia of breast cancer: clinicopathological features and predicting response.
Ogiya A; Horii R; Osako T; Ito Y; Iwase T; Eishi Y; Akiyama F
Breast Cancer; 2010 Oct; 17(4):290-7. PubMed ID: 19789945
[TBL] [Abstract][Full Text] [Related]
8. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
Ansai S; Koseki S; Hozumi Y; Kondo S
Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
[TBL] [Abstract][Full Text] [Related]
10. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
Wong TY; Suster S; Cheek RF; Mihm MC
Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
[TBL] [Abstract][Full Text] [Related]
11. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
Tramm T; Kim JY; Tavassoli FA
Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
[TBL] [Abstract][Full Text] [Related]
12. Syringocystadenoma papilliferum of the male breast.
Nowak M; Pathan A; Fatteh S; Fatteh S; Lopez J
Am J Dermatopathol; 1998 Aug; 20(4):422-4. PubMed ID: 9700386
[TBL] [Abstract][Full Text] [Related]
13. Cytologic features of pleural effusion in apocrine sweat gland carcinoma. A case report.
Otani M; Maeda Y; Miyake Y; Miura M; Kudo M; Ebihara Y
Acta Cytol; 2001; 45(1):74-8. PubMed ID: 11213508
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors.
Selim AG; Wells CA
J Clin Pathol; 1999 Nov; 52(11):838-41. PubMed ID: 10690175
[TBL] [Abstract][Full Text] [Related]
15. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.
Shim HS; Jung WH; Kim H; Park K; Cho NH
APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast.
Vranic S; MarchiĆ² C; Castellano I; Botta C; Scalzo MS; Bender RP; Payan-Gomez C; di Cantogno LV; Gugliotta P; Tondat F; di Celle PF; Mariani S; Gatalica Z; Sapino A
Hum Pathol; 2015 Sep; 46(9):1350-9. PubMed ID: 26208846
[TBL] [Abstract][Full Text] [Related]
17. Apocrine adenocarcinoma of the eyelid with aggressive biological behavior: report of a case.
Shintaku M; Tsuta K; Yoshida H; Tsubura A; Nakashima Y; Noda K
Pathol Int; 2002 Feb; 52(2):169-73. PubMed ID: 11940224
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
19. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE
Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521
[TBL] [Abstract][Full Text] [Related]
20. Apocrine epithelium of the breast: does it result from metaplasia?
Viacava P; Naccarato AG; Bevilacqua G
Virchows Arch; 1997 Sep; 431(3):205-9. PubMed ID: 9334842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]